Prof. Maria Mazurkiewicz-Bełdzińska at the Division of Developmental Neurology is implementing a drug programme for patients with spinal muscular atrophy. In patients who until recently have had little chance for a normal life, the disease progression has been put to a halt due to effective therapies. In newborns, thanks to screening and medication in the first month of life, SMA will most likely never generate any symptoms. A once fatal disease is now becoming chronic right in front of our eyes.